Patents by Inventor Danielle Ulanet

Danielle Ulanet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF A DHODH INHIBITOR COMPOUND IN COMBINATION CANCER THERAPY
    Publication number: 20230285364
    Abstract: Provided herein are method of treating cancers using a first anti-cancer agent and at least one second anti-cancer agent, wherein the first anti-cancer agent is represented by Formula (I): or a pharmaceutically acceptable salt thereof. Compositions comprising the disclosed first anti-cancer agent and at least one second anti-cancer agent are also provided.
    Type: Application
    Filed: June 23, 2021
    Publication date: September 14, 2023
    Inventors: John Coco, Joshua Murtie, Danielle Ulanet
  • Methods of use for trisubstituted benzotriazole derivatives
    Patent number: 11717512
    Abstract: The present invention provides methods for treating cancer in a subject with a trisubstituted benzotriazole derivative with the formula (I) or a pharmaceutically acceptable salt thereof, wherein the variables R1, R2 and R3 are as defined herein.
    Type: Grant
    Filed: February 19, 2019
    Date of Patent: August 8, 2023
    Assignee: Servier Pharmaceuticals LLC
    Inventors: Danielle Ulanet, Sung Eun Choe
  • METHODS OF USE FOR TRISUBSTITUTED BENZOTRIAZOLE DERIVATIVES
    Publication number: 20210113531
    Abstract: The present invention provides methods for treating cancer in a subject with a trisubstituted benzotriazole derivative with the formula (I) or a pharmaceutically acceptable salt thereof, wherein the variables R1, R2 and R3 are as defined herein.
    Type: Application
    Filed: February 19, 2019
    Publication date: April 22, 2021
    Inventors: Danielle Ulanet, Sung Eun Choe
  • Methods of evaluating patients using E-cadherin or vimentin
    Patent number: 10101331
    Abstract: Methods and kits for the selection, evaluation, and/or treatment of a patient having cancer with an inhibitor of a glutamine-utilizing enzyme or a glutamine-depleting agent, by evaluating E-cadherin or vimentin expression are disclosed.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: October 16, 2018
    Assignee: Agios Pharmaceuticals, Inc.
    Inventors: Jonathan Hurov, Sung Eun Choe, Danielle Ulanet
  • USE OF E-CADHERIN AND VIMENTIN FOR SELECTION OF TREATMENT RESPONSIVE PATIENTS
    Publication number: 20170299593
    Abstract: Methods and kits for the selection, evaluation, and/or treatment of a patient having cancer with an inhibitor of a glutamine-utilizing enzyme or a glutamine-depleting agent, by evaluating E-cadherin or vimentin expression are disclosed.
    Type: Application
    Filed: February 28, 2017
    Publication date: October 19, 2017
    Inventors: Jonathan Hurov, Sung Eun Choe, Danielle Ulanet
  • Methods of evaluating patients using E-cadherin and vimentin
    Patent number: 9618514
    Abstract: Methods for the selection, evaluation, and/or treatment of a patient having cancer with an inhibitor of a glutamine-utilizing enzyme or a glutamine-depleting agent, by evaluating E-cadherin or vimentin expression are disclosed.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: April 11, 2017
    Assignee: AGIOS PHARMACEUTICALS, INC
    Inventors: Sung Eun Choe, Jonathan Hurov, Danielle Ulanet
  • USE OF E-CADHERIN AND VIMENTIN FOR SELECTION OF TREATMENT RESPONSIVE PATIENTS
    Publication number: 20150276744
    Abstract: Methods and kits for the selection, evaluation, and/or treatment of a patient having cancer with an inhibitor of a glutamine-utilizing enzyme or a glutamine-depleting agent, by evaluating E-cadherin or vimentin expression are disclosed.
    Type: Application
    Filed: September 16, 2013
    Publication date: October 1, 2015
    Applicant: AGIOS PHARMACEUTICALS, INC
    Inventors: Sung Eun Choe, Jonathan Hurov, Danielle Ulanet